Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

High-resolution array CGH identifies novel regions of genomic alteration in intermediate-risk prostate cancer.

The Prostate - 1 Jul 2009

Ishkanian Adrian S, Mallof Chad A, Ho James, Meng Alice, Albert Monique, Syed Amena, van der Kwast Theodorus, Milosevic Michael, Yoshimoto Maisa, Squire Jeremy A, Lam Wan L, Bristow Robert G

Abstract excerpt

Approximately one-third of prostate cancer patients present with intermediate risk disease. Interestingly, while this risk group is clinically well defined, it demonstrates the most significant heterogeneity in PSA-based biochemical outcome. Further, the majority of candidate genes associated with prostate cancer progression have been identified using cell lines, xenograft models, and high-risk...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adenocarcinoma
Share to Cell Line, Tumor

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Cohort Studies

Share to Comparative Genomic Hybridization

Share to Gene Deletion

Share to Gene Expression Profiling

Share to Oligonucleotide Array Sequence Analysis

Share to Prostatic Neoplasms

Source

Identifiers

PMID: 19350549
DOI: 10.1002/pros.20959

Genes

CDH1
ERG
MYC
PTEN
TMPRSS2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

High-resolution array CGH identifies novel regions of genomic alteration in intermediate-risk prostate cancer.PMID 19350549Read ↗

Array CGH as a potential predictor of radiocurability in intermediate risk prostate cancerSemantic proximity Read ↗

Genomic Profiling Reveals Alternative Genetic Pathways of Prostate TumorigenesisSemantic proximity Read ↗

Integration of copy number and transcriptomics provides risk stratification in prostate cancer: A discovery and validation cohort studySemantic proximity Read ↗

Integrative Analysis of Genomic Aberrations Associated with Prostate Cancer ProgressionSemantic proximity Read ↗

High-Resolution Analysis of Gene Copy Number Alterations in Human Prostate Cancer Using CGH on cDNA Microarrays: Impact of Copy Number on Gene ExpressionSemantic proximity Read ↗

High-Resolution Analysis of Gene Copy Number Alterations in Human Prostate Cancer Using CGH on cDNA Microarrays: Impact of Copy Number on Gene ExpressionSemantic proximity Read ↗

The genomic complexity of primary human prostate cancerSemantic proximity Read ↗

The Diverse Genomic Landscape of Clinically Low-risk Prostate CancerSemantic proximity Read ↗

Comprehensive assessment of DNA copy number alterations in human prostate cancers using Affymetrix 100K SNP mapping arraySemantic proximity Read ↗

Genomic hallmarks of localized, non-indolent prostate cancer.Semantic proximity Read ↗

Genetic alterations in the 3q26.31-32 locus confer an aggressive prostate cancer phenotype.Semantic proximity Read ↗

Cribriform and intraductal prostate cancer are associated with increased genomic instability and distinct genomic alterationsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.